Pages that link to "Q43001837"

The following pages link to Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat. (Q43001837):

Displaying 47 items.

• Proceedings: A possible mode of action of piperazine (Q35175270) (← links)
• Studies on the hypotensive action of alpha-methyldopamine (Q35175422) (← links)
• Antihypertensive drugs: clinical pharmacology and therapeutic use. (Q38071275) (← links)
• Central α-adrenergic systems as targets for hypotensive drugs (Q38284791) (← links)
• Studies on the mechanism of the cardiovascular effects of methyldopa (Q39097308) (← links)
• Effects of α-methyldopa on blood pressure in the anaesthetized dog (Q39099385) (← links)
• Effects of methyldopa on psychometric performance (Q39264684) (← links)
• Selective stimulation of central ?-autoreceptors following treatment with ?-methyldopa and FLA 136 (Q39265443) (← links)
• Central nervous system mechanisms in blood pressure control (Q39398904) (← links)
• Prolonged effects of p-chlorophenylalanine on the blood pressure of conscious normotensive and DOCA/saline hypertensive rats (Q39761965) (← links)
• On the role of ?-methyldopamine in the antihypertensive effect of ?-methyldopa (Q39949154) (← links)
• Proceedings: Hypotensive action of alpha-methyldopamine (Q40004624) (← links)
• Proceedings: A centrally-acting antihypertensive agent R28935, a pimozide analogue, not acting via alpha-adrenergic neurones (Q40009316) (← links)
• Proceedings: Prostaglandin D1 inhibits the increase in vascular permeability in rat skin produced by prostaglandin E1, E2 and D2 (Q40010646) (← links)
• Centrally induced hypotension and bradycardia after administration of alpha-methylnoradrenaline into the area of the nucleus tractus solitarii of the rat (Q40026395) (← links)
• Ontogenesis of the multiple forms of choline acetyltransferase: uptake and acetylation of choline in rat brain [proceedings] (Q40030053) (← links)
• Cardiovascular responses to centrally administered adrenaline in spontaneous hypertensive rats [proceedings] (Q40031417) (← links)
• Effects of several catecholamines in symphathetic transmission to the myocardium: Role of presynaptic α-adrenoceptors (Q40065275) (← links)
• Central monoamine systems and new antihypertensive agents (Q40516262) (← links)
• Centrally Induced Hypotension by α-Methyldopa and α-Methylnoradrenaline in Normotensive and Renal Hypertensive Rats (Q40832674) (← links)
• Hypotension and hypothalamic amine metabolism after long-term α-methyldopa infusions (Q40936200) (← links)
• The effect of acute α-methyldopa administration on catecholamine levels in anterior hypothalamic-preoptic and medullary nuclei in rat brain (Q41039586) (← links)
• The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects (Q41496886) (← links)
• Endogenous and α-methylated catecholamine levels in anterior hypothalamic-preoptic and medullary nuclei in rat brain after chronic α-methyldopa administration (Q41583272) (← links)
• Effects of noradrenergic stimulation of the medial and lateral hypothalamus on cardiovascular responses (Q41586874) (← links)
• Importance of central serotonin neurons in the hypotensive action of methyldopa in the rat. (Q41863693) (← links)
• Studies on the mechanism of methyl-dopa-induced mydriasis in the cat. (Q41625046) (← links)
• The influence of SK & F 64139, a phenylethanolamine-N-methyltransferase inhibitor, on centrally mediated cardiovascular effects of ?-methyldopa and clonidine (Q42241833) (← links)
• Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs (Q42701305) (← links)
• Evidence for an inhibitory action of methyldopa on spinal sympathetic reflexes (Q43737826) (← links)
• Central Inhibitory Noradrenergic Cardiovascular Control (Q44736898) (← links)
• Centrally mediated increased sympathetic activity is not important in the genesis of ACTH-induced hypertension in sheep (Q46813171) (← links)
• Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents (Q48330111) (← links)
• Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy (Q48371416) (← links)
• α-Methylnoradrenaline induced hypotension and bradycardia after administration into the area of the nucleus tractus solitarii (Q48458331) (← links)
• Inhibition of the activity of sympathetic preganglionic neurones and neurones activated by visceral afferents, by alpha-methylnoradrenaline and endogenous catecholamines (Q48846927) (← links)
• Comparison of hypotensive, orthostatic and sympathetic inhibitory actions of antihypertensive drugs in rats. (Q51870040) (← links)
• Effects of methyldopa on prolactin and growth hormone (Q54984639) (← links)
• Effect of methyldopa treatment on peripheral sympathetic nerve function in the dog (Q66897885) (← links)
• Central mediation of the antihypertensive effect of pargyline in spontaneously hypertensive rats (Q66923520) (← links)
• Effects of psychotropic drugs on pressor and behavioral responses to brain stimulation in unrestrained, unanesthetized rats (Q66932443) (← links)
• Central inhibitory effect of α-methyldopa on blood pressure, heart rate and body temperature of renal hypertensive rats (Q66956685) (← links)
• Effect of clonidine on sleep patterns in man (Q67052555) (← links)
• A centrally acting antihypertensive agent (R28935) not mediated via central α-adrenoreceptors (Q67324094) (← links)
• Protective effect of adrenergic blocking agents against kidney hemorrhagic necrosis of choline deficiency (Q70484980) (← links)
• The effect on plasma prolactin, growth hormone and luteinising hormone concentrations of single oral doses or propranolol and tolamolol in normal man (Q71886395) (← links)
• Methyldopa produces central inhibition of parasympathetic activity in the cat (Q72876745) (← links)